Aberrant DNA methylation as a diagnostic biomarker of diabetic embryopathy.

Katharina V SchulzeAmit BhattMahshid S AzamianNathan C SundgrenGladys E ZapataPatricia HernandezKarin FoxJeffrey R KaiserJohn W BelmontNeil A Hanchard

Published in: Genetics in medicine : official journal of the American College of Medical Genetics (2019)

Our study suggests a role for aberrant DNA methylation and cis-sequence variation in the pathogenesis of DE and highlights the diagnostic potential of DNA methylation for teratogenic birth defects.

Keyphrases

dna methylation
genome wide
gene expression
type diabetes
gestational age
pregnant women